Skip to main content
. 2015 Sep 1;8(9):10922–10928.

Figure 3.

Figure 3

ADAM17 is identified as a target of miR-338-3p in gastric cancer. A. The wild type and mutant ADAM17 3’UTR sequences are shown with the miR-338-3p sequence. B. Luciferase assay in HEK293T cells with wild-type or mutant ADAM17 3’UTR vectors and miR-338-3p mimics or negative control. C. ADAM17 expression in BGC-823 cells transfected with miR-338-3p mimics or negative control was detected by Western blot. *P<0.05.